Envista Holdings Corporation Stock News

Envista press release (NVST): Q4 Non-GAAP EPS of $0.46 beats by $0.04.Revenue of $651.8M (+5.8% Y/Y) beats by $17.12M.For 2022, barring any significant COVID related disruptions,…

Envista Holdings Corporation's (NVST) CEO Amir Aghdaei on Q4 2021 Results - Earnings Call Transcript

Envista (NVST) delivered earnings and revenue surprises of 9.52% and 2.94%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Envista (NYSE:NVST) is scheduled to announce Q4 earnings results on Wednesday, February 9th, after market close.The consensus EPS Estimate is $0.42 (-25.0% Y/Y) and the consensus…

Envista (NVST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Envista (NVST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The stock price of Envista Holdings Corporation (NYSE: NVST) increased by 0.37% in the most recent trading session. This is why it happened.

Envista Holdings Corporation (NVST) announced an expansion to the company’s partnership with the dental support organization, Pacific Dental Services ((PDS)).Per the terms, the duo…

Upgrades UBS upgraded the previous rating for Align Technology Inc (NASDAQ:ALGN) from Neutral to Buy. For the third quarter, Align Tech had an EPS of $2.87, compared to year-ago quarter EPS of $2.25.

BREA, Calif., Jan. 19, 2022 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2021 on Wednesday, February 9, 2022.

Envista Holdings Corp (NVST) shares closed today at 1.2% below its 52 week high of $46.88, giving the company a market cap of $7B. The stock is currently up 2.8% year-to-date, up 29.5% over the past 12 months, and up 65.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 5.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -246.6% The company's stock price performance over the past 12 months beats the peer average by -235.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 229.2% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Envista Holdings Corp (NVST) shares closed today at 1.2% below its 52 week high of $46.88, giving the company a market cap of $7B. The stock is currently up 2.8% year-to-date, up 31.6% over the past 12 months, and up 65.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 5.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -246.6% The company's stock price performance over the past 12 months beats the peer average by -241.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 229.2% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Envista (NVST) noted that the Nobel Biocare N1 system represents a significant step further in patient-centric dental implant solutions.